SCHEMBL171303

SCHEMBL171303

SC1CCN(Cc2ccccc2)C1

nearest known ligand 0.81

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.81
CYP3A4 P08684 1/20 0.81
CYP2D6 P10635 1/20 0.81
CYP2C19 P33261 1/20 0.81
ACHE P22303 9/20 0.58
BCHE P06276 8/20 0.57
BACE1 P56817 8/20 0.57
CCR3 P51677 1/20 0.56
ALDH1A1 P00352 1/20 0.56
SIGMAR1 Q99720 2/20 0.55
DRD2 P14416 1/20 0.53
DRD4 P21917 1/20 0.53
DRD3 P35462 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6399821 1.00 CYP1A2 (0.81) CYP1A2CYP3A4CYP2D6CYP2C19ACHE
SCHEMBL6400502 0.89 CYP2D6 (1.00) CYP1A2CYP3A4CYP2D6CYP2C19ACHE
SCHEMBL9031040 0.89 ACHE (0.67) CYP1A2CYP3A4CYP2D6CYP2C19ACHE
SCHEMBL2920284 0.84 CYP1A2 (0.68) CYP1A2CYP3A4CYP2D6CYP2C19ACHE
Hydrochloric Acid SCHEMBL3104474 0.82 CYP1A2 (0.66) CYP1A2CYP3A4CYP2D6CYP2C19ACHE
SCHEMBL6399734 0.82 CYP1A2 (0.57) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL6403439 0.82 ACHE (0.60) CYP1A2CYP3A4CYP2D6CYP2C19ACHE
SCHEMBL6399377 0.80 CHRNB2 (0.59) CYP1A2CYP3A4CYP2D6CYP2C19ALDH1A1
SCHEMBL6399343 0.80 SIGMAR1 (0.61) CYP1A2CYP3A4CYP2D6CYP2C19CCR3
SCHEMBL5858096 0.79 ACHE (0.59) CYP1A2CYP3A4CYP2D6CYP2C19ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9895443-B2 Multi-tailed lipids and uses thereof MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-02-20 US disclosed
EP-1670460-B1 PYRAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS BRISTOL MYERS SQUIBB CO (US) 2014-11-26 EP disclosed
EP-1768966-B1 COUMPOUNDS AND METHODS FOR INHIBITING THE INTERACTION OF BCL PROTEINS WITH BINDING PARTNERS INFINITY DISCOVERY INC (US) 2012-03-07 EP disclosed
US-20050004092-A1 Penem derivatives and antimicrobial agent containing the same DAIICHI SUNTORY PHARMA CO., LTD. (JP) 2005-01-06 US disclosed
EP-0757051-B1 PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME DAIICHI SUNTORY PHARMA CO LTD (JP) 2003-10-29 EP disclosed
US-6051569-A 1'S, 5R, 6R-carbapenem derivatives and antimicrobial agents comprising the same SUNTORY LIMITED (JP) 2000-04-18 US disclosed
EP-0826687-A1 Carbapenem derivatives and antimicrobial agents comprising the same SUNTORY LIMITED (JP) 1998-03-04 EP disclosed
EP-0774465-A1 Penem derivatives and antimicrobial agents containing the same SUNTORY LIMITED (JP) 1997-05-21 EP disclosed
EP-0757051-A1 PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME SUNTORY LIMITED (JP) 1997-02-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004092-A1 Penem derivatives and antimicrobial agent containing the same MRPL21, MRPS2, MRPS28 CYP1A2 3030/4885CYP3A4 3356/4885CYP2D6 1885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.